Systemic antibiotic therapy in everyday practice: Throat infection. General method, recommendations and discussion;Antibiothérapie par voie générale en pratique courante: Angine: Méthode générale, recommandations et argumentaire

Archives de Pediatrie

Volumn 10, Issue 3, 2003, Pages 260-271

  Turkheim, H ^a  

^a NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BACAMPICILLIN; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFATRIZINE; CEFOTIAM HEXETIL; CEFPODOXIME PROXETIL; CEFRADINE; CEFUROXIME AXETIL; CLARITHROMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; ERYTHROMYCIN PROPIONATE; JOSAMYCIN; LORACARBEF; MIOKAMYCIN; PENICILLIN G; PENICILLIN V; PIVAMPICILLIN; ROXITHROMYCIN; SPIRAMYCIN;

ANGINA PECTORIS; ANTIBIOTIC THERAPY; ARCANOBACTERIUM; BETA HEMOLYTIC STREPTOCOCCUS; CORYNEBACTERIUM DIPHTHERIAE; DRUG EFFICACY; DRUG INDICATION; ERADICATION THERAPY; GENERAL PRACTICE; HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; NEISSERIA GONORRHOEAE; NONHUMAN; PARAINFLUENZA VIRUS; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0038537577     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)00037-X     Document Type: Review

References (80)

1. Peyramond D, Raffi F, Lucht F, Leboucher G. Traitements antibiotiques des angines. Indications, modalités, durées. Méd Mal Infect 1997;27(spécial):434-49.
2. Bisno AI. Acute pharyngitis: Etiology and diagnosis. Pediatrics 1996;97(6 pt 2):949-54.
3. Dixième conférence de consensus en thérapeutique anti-infectieuse - 19 juin 1996, Lyon: les infections ORL Méd Mal Infect. Spécial 1997;27:334-54.
4. Mallet E. Étiologie, expression clinique de I'angine. Méd Mal Infect 1997;27(Spécial):418-23.
5. Bisno AI, Chairman, Gerber MA, Gwaitney JM, Kaplan Ele, Schwartz R. Diagnosis and Management of Group A Streptococcal Pharyngitis: A pratice Guideline. Clin Infect Dis 1997;25:574-83.
6. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995;96(4 Pt 1):758-64.
7. Schwartz B, Marcy S, Phillips WR, Gerber MA, Dowell SF. Pharyngitis - Principles of judicious use of antimicrobial agents. Pediatrics 1998;101(1 Suppl S):171-4.
8. Mac Isaac WJ, Goel V, Slaughter PM, Parsons GW, Woolnough KV, Weir PT, Ennet JR. Reconsidering sore throats. Part 2: Alternative approach and practical office tool. Can Fam Physician 1997;43:495-500.
9. Stillerman M, Bernstein SH. Streptococcal pharyngitis: evaluation of clinical syndroms in diagnosis. Am J Dis Child 1961;101:476-89.
10. Cohen R, Chaumette L, Bingen E, De Gouvello A, De La Rocque E. L'avenir dans l'angine: les tests de diagnostic rapide. Méd Mal Infect 1997;27(special):424-33.
11. Gerber MA, Tanz RR, Kabat W, Dennis E, Bell GL, Kaplan EL, Shulman ST. Optical Immunoassay Test for Group A bêta-hemolytic Streptococcal Pharyngitis. Jama 1997;277(vol II):899-903.
12. Cohen R, Varon E, De La Rocque F, Lecompte MD, Wollner A, Geslin P. Stratégies de la thérapeutique de l'angine streptococcique et test de diagnostic rapide. Lettre de l'infectiologue 1994;9:583-6.
13. Portier H, Peyramond D, Boucot I, Grappin M, Boibieux A, Pribil C. GRAPH: évaluation de l'applicabilité du consensus sur la prise en charge de l'angine chez l'adulte. Méd mal infect 2001;31:388-95.
14. Gerber MA. comparison of throat cultures and rapid tests for diagnosis of streptococcal pharyngitis. pediatr infect dis 1989;8:820-4.
15. Brink WR, Rammelkamp CH, Denny FW, Wannamaker LW. effect of penicillin and aureomycin on the natural course of steptococcal tonsilitis and pharyngitis. am J med 1951;10:300-8 Agence française de sécurité sanitaire des produits de santé, 27/01/03 20.
16. Shulman S. Complications of streptococcal pharyngitis. Pediatr Infect Dis J 1994;13(1):S:70-4.
17. Peter G, Smith AI. Group A streptococcal infections of the skin and pharynx. N Engl J Med 1977;297:365-70.
18. Anonyme. Diagnosis and treatment of streptococcal sore throat. Drugs Ther Bul 1995;33(2):9-12.
19. Little P, Williamson I, Warmer G, Gould C, Gantley M, Kinmonth AI. Open randomised trial of prescribing strategies in managing sore throat. Br Med J 1997;314:722-7.
20. Bisno AI. Group A streptococcal infectious and acute rheumatic fever. N Engl J Med 1991;325(11):783-93.
21. Veasy GL, Lloyd YT, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994;Vol 124:9-16.
22. Mac Isaac WJ, Goel V, Slaughter PM, Parsons GW, Woolnough KV, Weir PT, Ennet JR. Reconsidering sore throats. Part 1: Problems with current clinical practice. Can Fam Physician 1997;43:485-93.
23. Olivier C. and the Graph group: Acute Rheumatic Fever (ARF) in France: incidence of a first episode during the period 1995-1997 in the 5-14 years old children. 38th ICAAC, 1998, Session 144L, abstract L90.
24. Markowitz M. Streptococcal disease in developing countries. Pediatr Infect Dis 1991;10(10) (suppl):S11-4.
25. Bach JF, Charlons S, Forier E, Elana G, Jouanelle J, Kayemba S, Delbois D, Mosser A, Saint-Aimé C, Berchel C.: 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 1996;347:644-8.
26. Denny FW. A 45 year prospective on the streptococcus and rheumatic fever: the Edward H. Kass lecture in infectious disease history. Clin Infect Dis 1994;19:1110-22.
27. Taylor JL, Howie J. Antibiotics sore throat and acute nephritis. J R Coll Gen Pract 1968;33:783-6.
28. Dagnelie CF, Van Der Graaf Y, De Melker RA, Touw-Otten FW. Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract 1996;46(411):589-93.
29. Randolph MF, Gerber MA, Demeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr 1985;106:870-5.
30. Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis: placebo controlled double blind evaluation of clinical response to penicillin therapy. Jama 1985;253:1271-4.
31. Snellman LW, Stang HJ, Johnson DR, Kaplan EL. Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. Pediatrics 1993;91(6):1166-70.
32. Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH, Custer EA. Prevention of rheumatic fever: treatment of the preceding streptococci infection. Jama 1950;143:151-3 Agence française de sécurité sanitaire des produits de santé, 27/01/03 21.
33. Wood HF, Feinstein AR, Taranta A, Epstein JA, Simpson R. Rheumatic fever in children and adolescents. A long term epidemiologic study of subsequent prophylaxis streptococcal infections and clinical sequelae. III. Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences. Ann Int Med 1964;60(suppl 5):31-46.
34. Del Mar C. Managing sore throat: a literature review - II - Do antibiotics confer benefit?. Med J Austr 1992;156:644-9.
35. Weinstein L, Le Frock J. Does antimicrobial therapy of streptococcal pharyngitis or pyoderma alter the risk of glomerulonephritis?. J Infect Dis 1971;124:229-31.
36. Little P, Williamson I. Sore throat management in general practice. Fam Pract 1996;13(3):317-21.
37. Wannamaker LW, Rammelkamp CH, Denny FW, Brink WR, Houser HB, Hahn EO. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infectious with various amounts of depot peniciliin. Jama 1951;10:673-95.
38. Gastanaduy AS, Kaplan LE, Huwe BB, Mc Kay C, Wannamaker LW. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980;2:498-502.
39. Pichichero ME. Contreversies in the treatment of streptococcal pharyngitis. Am Fam Phys 1990;42:1567-76.
40. Markowitz M, Gerber MA, Kaplan EL. Treatment of steptococcal pharyngitis: reports of penicillin's demise are premature. J Pediatr 1993;123:679-85.
41. Gehanno P, Chiche D. Traitement des angines à streptocoque bêtahémolytique du groupe A par le céfuroxime-axétil pendant 4 j: étude comparative à la pénicillin V pendant 10 j. Med Mal Infect 1991;21:66-70.
42. Portier H, Chavanet P, Gouyon JB, Guetat F. Five-day treatment of pharyngotonsillitis with cefpodoxime-proxetil. J Antimicrob Chemother 1990;26(Suppl E):79-85.
43. Portier H, Chavanet P, Walder-Combernoux A, Kisterm Ann JP, Grey PC, Ichou F, Safran C. Five vs 10 days treatment of streptococcal pharyngotonsilitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Scand J Infect Dis 1994;26:59-66.
44. Aujard Y, Boucout I, Brahimi N, Chiche D, Bingen E. Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children. Pediatr Infect Dis J 1995;14:295-300.
45. Cohen R, Lewy C, Doit C, De La Rocque F, Boucherat M, Fitoussi F, Langue J, Bingen E. Six-day amoxicillin versus ten-day penicillin V in group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 1996;15:678-82.
46. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997;16:680-95.
47. Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal illness. Comparison of lincomycin, ampicillin, and potassium penicillin G in treatment. Am J Dis Child 1966;112:21-7.
48. Breese BB, Disney FA, Talpey WB, Green JL. Treatment of streptococcal pharyngitis with amoxicillin. J Infect Dis 1974;129(Suppl): S178-80 Agence Française de Sécurité Sanitaire des Produits de Santé, 27/01/03 22.
49. Breese BB, Disney FA, Green JL, Talpey WB. The treatment of beta hemolytic streptococcal pharyngitis: comparison of amoxicillin, erythromycin estolate, and penicillin V. Clin Pediatr 1977;16:460-3.
50. Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of streptococcal pharyngitis with amoxicillin once a day. Br Med J 1993;306:1170-2.
51. Stillerman M, Isenberg HD, Moody M. Streptococcal pharyngitis therapy: comparison of cephalexin, phenoxymethyl penicillin, and ampicillin. Am J Dis Child 1972;123:457-61.
52. Stillerman M, isenberg HD, Facklam RR. Session II. Use of amoxicillin in various respiratory infections: pharyngitis. Treatment of pharyngitis associated with Group A Streptococcu s: comparison of amoxicillin and potassium phenoxymethyl penicillin. J Infect Dis 1974;129:S169-77.
53. Ström J. A comparison for the effects and side-effects of penicillin V and ampicillin in treatment of scarlet fever. Acta Paediatr Scand 1968;57:285-8.
54. Peyramond D, Portier H, Geslin P. Cohen R.: 6-day amoxicillin vs 10-day penicillin V for group A - hemolytic streptococcal acute tonsillitis in adults: a French multicentre, open label, randomized study. Scand J Infect Dis 1996;28:497-501.
55. Blumer JL, Goldfarb J. Meta-analysis in the evaluation of treatment for streptococcal pharyngitis: a review. Clin Ther 1994;16(4):604-20.
56. Deeter RG, Kalman DL, Rogan MP, Chow SC. Therapy for pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate vs oral penicillin V. Clin Ther 1992;14:740-54.
57. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta haemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 1991;10:275-81.
58. Carbon C, Chatelin A, Bingen E, Zuck P, Rio Y, Guetat F, Orvain J. A double blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis cause by group A beta-haemolytic streptococci. J Antimicrob Chemother 1995;35:843-54.
59. Schito GC, Pesce A, Marchese A. The role of macrolides in Streptococcus pyogenes pharyngitis. J Antimicrob Chemother 1997;39:562-5.
60. Seppälä H, Klaukka T, Lehtonen R, Nenonen E, the Finnish Study group for Antimicrobial resistance, Huovinen P. Out-patient use of erythromycin: Link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995;21:1378-85.
61. Seppälä H, Klaukka T, Lehtonen R, Nenonen E, Huovinen PP. Erythromycin resistance of group A streptococcus from throat sample is related to age. Pediatr Infect Dis J 1997;16:651-6.
62. Bingen E, Fitoussi F, Doit C, Cohen R, Tanna A, George R, Loukil C, Brahimi N, Le Thomas I, Deforche D. Resistance to Macrolides in Streptococcus pyogenes in France in Pediatric Patients. Antimicrob Agents Chemother 2000;44:1453-7.
63. Weber Ph, Filipecki J, Bingen E, Fitoussi G, Goldfarb G, Chauvin JP, Reitz C, Portier H. Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemother 2001;48:291-4 Agence française de sécurité sanitaire des produits de santé, 27/01/03 23.
64. Cohen R, Fremaux A, De Gouvello A, Deforche V, Levy C, Wadbled D, De La Rocque E, Varon E, Geslin P. Sensibilité in vitro de souches de Streptococcus pyogènes récemment isolées d'angines communautaires. Méd Mal Infect 1996;26:765-9.
65. e R.I.C.A.I. PARIS. 1996 Abstract 15/C2.
66. Portier H, Lucht F, Lescale O, Kazmierczak A, Ros A, Scheimberg A. Josamycine 5 jours vs Pénicilline V 10 j dans le traitement desangines à Streptocoque du groupe A. Méd Mal Infect 1995;25:1005-10.
67. Portier H, Bourillon A, Lucht F, Choutet P, Gehanno P, Meziane L, Bingen E. Traitement des angines aiguës à streptocoque bêtahémolytique du groupe A chez l'enfant par la josamycine pendant 5 j. Archives de Pédiatrie 2001;8:700-6.
68. Portier H, Filipecki J, Weber Ph, Goldfarb G, Lethuaire D, Chauvin JP. Five day clarithromycin modified release vs 10 days penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomised study. J Antimicrob Chemother 2002;49:337-44.
69. Nelson TD. The effect of penicillin therapyon the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis J 1984;3:10-3.
70. Pichichero ME, Disney FA, Talpey WB, Green JL, Francis AB, Roghmann KJ, Hoekelman RA. adverse and beneficial effects of immediate treatment of group A beta hemolytic streptococcal pharyngitis with penicillin. Pediatr Infect Dis J 1987;6:635-43.
71. Catanzaro FJ, Stetson CA, Morris AJ, Chamovitz R, Rammelkamp Ch, Stolzer BL, Perry WD. the role of steptoccoccus in the pathogenesis of rheumatic fever. am j med 1954;17:749-56.
72. El-Dahler NT, Hijazi S, Rawashdeh NM, Al-khalil IAH, Abu-Ektaish FM, Abdel-Latif DI, Immediate VS. Delayed treatment of group a beta hemolytic streptococcal pharyngitis with penicillin v. pediatr infect dis j 1991;10:126-30.
73. Gerber MA, Randolph M, Demeo KK, Kaplan EI. lack of impact of early antibiotic therapy for streptococcal pharyngitis on recurrence rates. j pediatr 1990;117:853-8.
74. Catanzaro FJ, Rammelkamp Ch, chamovitz R. prevention of rheumatic fever by treatment of streptococcal infectious I.I. factors reponsible for failures. N Engl J med 1958;259:51-7.
75. Costagliola D, Ropers J. évaluation de l'impact a priori d'une nouvelle recommandation fondée sur l'utilisation de tests de diagnostic rapide pour le diagnostic et le traitement des angines. Approche par simulation. Agence du médicament. Rapport interne, octobre 1998.
76. Portier H, Gehanno P, Weber P, Dabernat H, Ichou F, Clermont A, Fiessinger S. Efficacy of 5-day cefpodoxime-proxetil for recurrent pharyngitis in adults. A comparison study with 10-day penicillin v or amoxycillin-clavulanate. Clin microbiol infect 1997;3:447-54.
77. Mouton Y, Bignolas G, Chidiac C, Decazes JM, Gehanno P. recommandations sur la prise en charge de la pathologie infectieuse respiratoire. Méd mal infect 1995;25:1021-8.
78. Snow V, Mottur-Pilson C, Cooper J, Hoffman R. principles of appropriate antibiotic use for acute pharyngitis in adults. Ann intern med 2001;134:506-8 agence française de sécurité sanitaire des produits de santé, 27/01/03 24.
79. Bisno AI, Gerber MA, Gwaltney JM, Kaplan EI Schwartz RH. practice guideline for the diagnosis and management of group a streptococcal pharyngitis. Clin infect dis 2002;35:113-25.
80. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981;1:239-46.